The U.S. Congress will try this week to end months of indecision and infighting over the federal government's budget priorities and coronavirus aid, with more than $2 trillion in funding from Washington potentially at stake.
U.S. President Donald Trump has until Dec. 23 to decide whether to veto the $740 billion National Defense Authorization Act or allow the annual measure setting policy for the Department of Defense to become law, a House of Representatives aide said on Monday.
Wall Street's main indexes rose on Monday as travel stocks surged on the launch of a nationwide COVID-19 vaccine campaign, while Alexion Pharmaceuticals jumped on a $39 billion buyout offer from AstraZeneca (NASDAQ:AZN) in one of the year's biggest deals.
Europe's banks are not integrating climate change and other sustainability concerns into their risk management systems as quickly as regulators expect, a study by BlackRock (NYSE:BLK) for the European Union showed on Monday.
Zoom fatigue? Isolation from colleagues? A craving for lamb shawarma from the downtown food truck?